Table II.
N=252 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
Yahr stage 1 | Yahr stage 2 | Yahr stage 3 | Yahr stage 4 | Yahr stage 5 | |||||||
|
|||||||||||
n | average±SD | n | average±SD | n | average±SD | n | average±SD | n | average±SD | ||
age | PD | 16 | 71.5±4.9 | 31 | 70.5±6.3 | 96 | 72.4±6.6 | 63 | 74.5±6.0 | 22 | 78.9±6.9 |
YOPD | 1 | 81.0±0.0 | 3 | 63.0±7.9 | 10 | 61.9±10.6 | 6 | 59.0±10.5 | 4 | 59.5±10.7 | |
| |||||||||||
Disease Duration (Years) | PD | 16 | 6.0±3.3 | 31 | 7.7±4.4 | 93 | 11.1±6.0 | 62 | 15.5±11.6 | 22 | 19.1±13.8 |
YOPD | 1 | 16.0±0.0 | 3 | 10.3±4.0 | 10 | 21.7±8.7 | 6 | 19.0±3.9 | 4 | 14.3±2.2 | |
| |||||||||||
Number of Types of Medicines (for PD) | PD | 16 | 2.4±1.1 | 30 | 3.1±1.5 | 90 | 4.2±1.7 | 59 | 4.8±2.5 | 21 | 4.0±2.7 |
YOPD | 1 | 2.0±0.0 | 3 | 7.7±5.0 | 9 | 6.0±3.4 | 5 | 6.0±4.2 | 4 | 4.8±2.8 | |
| |||||||||||
Number of Days to Next Appointment | PD | 16 | 42.1±14.0 | 29 | 55.1±24.7 | 94 | 48.6±22.1 | 61 | 46.2±24.2 | 17 | 55.1±27.3 |
YOPD | 1 | 30.0±0.0 | 3 | 27.0±5.2 | 10 | 40.6±29.7 | 6 | 38.0±22.5 | 2 | 60.0±42.4 | |
| |||||||||||
(breakdown, %) | (breakdown, %) | (breakdown, %) | (breakdown, %) | (breakdown, %) | |||||||
| |||||||||||
People with motor fluctuation | PD | 16 | 2 (12.5%) | 31 | 9 (29.0%) | 96 | 43 (44.8%) | 63 | 32 (50.8%) | 22 | 10 (45.5%) |
YOPD | 1 | 0 (0.0%) | 3 | 1 (33.3%) | 10 | 6 (60.0%) | 6 | 5 (83.3%) | 4 | 3 (75.0%) | |
| |||||||||||
Off Time Per Day (Only People with motor fluctuation) | PD | 5 | 2.4±0.9 | 12 | 3.6±1.4 | 51 | 4.1±3.1 | 39 | 4.4±3.2 | 9 | 5.0±2.4 |
YOPD | 0 | - | 2 | 8.0±2.8 | 6 | 3.8±2.0 | 4 | 6.3±5.9 | 1 | 20.0±0.0 |